University of Pennsylvania Breast Cancer Vaccines Look Promising

HealthDay News -- Women with metastatic breast cancer who developed an immune response to an investigational vaccine lived twice as long as those who didn’t have an immune response, new research shows.

MORE ON THIS TOPIC